Document is current
Any future updates will be listed below
-
Authors
Kasikis, Stelios
Baez, Janna
Gandhi, Isha
Grupp, Stephan https://orcid.org/0000-0001-8030-7595
Kitko, Carrie L.
Kowalyk, Steven
Merli, Pietro https://orcid.org/0000-0001-6426-4046
Morales, George
Pulsipher, Michael A. https://orcid.org/0000-0003-3030-8420
Qayed, Muna
Wölfl, Matthias
Yanik, Gregory
See, Fiona
Hayes, Jack
Grossman, Fred
Burke, Elizabeth
Young, Rachel
Levine, John E.
Ferrara, James L. M. https://orcid.org/0000-0001-8595-3940
-
Funding
Funding for this research was provided by:
Pediatric Cancer Foundation (N/A, N/A)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P01CA039542, P30CA196521)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 18 May 2021
Revised: 29 July 2021
Accepted: 18 August 2021
First Online: 1 September 2021
Competing interests
: FS, JH, FG and EB are employees of Mesoblast. JEL and JLMF have received consulting fees from Mesoblast and royalties from a GVHD biomarker patent.
